Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 42 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 25 | 1,006−5.7%/yr | −5.7%/yr | 2.91.1× | 5% | 1,000 in 2030−0.1%/yr |
| Lumbar fusion | 25 | 965+0.5%/yr | +0.5%/yr | 2.81.4× | 0% | 1,000 in 2030+0.5%/yr |
| Cervical fusion & disc arthroplasty | 4 | 398−6.3%/yr | −6.3%/yr | 1.21.1× | 0% | 400 in 2030+0.2%/yr |
| Kyphoplasty & vertebroplasty | 2 | 191−16%/yr | −16%/yr | 0.60.7× | 39% | 210 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 174 | 34,360−4.3%/yr | −4.3%/yr | 98.61.1× | 31% | 42,800 in 2030+3.7%/yr |
| Skin substitutes & wound grafts | 15 | 3,005+7.9%/yr | +7.9%/yr | 5.31.1× | 50% | 4,060 in 2030+5.1%/yr |
| Bone graft & orthobiologics | 5 | 234−7.1%/yr | −7.1%/yr | 0.71.5× | 0% | 240 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 35 | 2,271−2.6%/yr | −2.6%/yr | 6.50.9× | 94% | 3,630 in 2030+8.1%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 5 | 276+9.9%/yr | +9.9%/yr | 0.81.1× | 30% | 610 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 39 | 2,246−8.9%/yr | −8.9%/yr | 6.42.0× | 100% | 2,440 in 2030+1.4%/yr |
| Dialysis access | 14 | 1,941−9.9%/yr | −9.9%/yr | 6.11.1× | 87% | 1,830 in 2030−1%/yr |
| Peripheral arterial intervention | 14 | 1,650−9%/yr | −9%/yr | 4.70.9× | 71% | 1,560 in 2030−1%/yr |
| Thrombectomy, IVC filters & venous stents | 1 | 474−5.9%/yr | −5.9%/yr | 1.41.1× | 23% | 420 in 2030−1.9%/yr |
| Carotid revascularization | 1 | 337−3.8%/yr | −3.8%/yr | 1.01.0× | 0% | 320 in 2030−1%/yr |
| Aortic endografts (EVAR/TEVAR) | 1 | 160−6.4%/yr | −6.4%/yr | 0.51.1× | 0% | 150 in 2030−0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 25 | 1,918−2.5%/yr | −2.5%/yr | 6.21.0× | 0% | 2,470 in 2030+4.3%/yr |
| Cholecystectomy & appendectomy | 13 | 1,125−6.5%/yr | −6.5%/yr | 3.51.0× | 0% | 1,160 in 2030+0.5%/yr |
| Colorectal resection | 2 | 469−8.4%/yr | −8.4%/yr | 1.50.9× | 0% | 480 in 2030+0.5%/yr |
| Antireflux & hiatal hernia surgery | 4 | 214−7.4%/yr | −7.4%/yr | 0.61.1× | 0% | 200 in 2030−0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 39 | 1,628−1.4%/yr | −1.4%/yr | 5.00.9× | 4% | 1,890 in 2030+2.5%/yr |
| BPH procedures | 20 | 1,316+0.2%/yr | +0.2%/yr | 3.90.9× | 19% | 1,290 in 2030−0.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 9 | 999−0.1%/yr | −0.1%/yr | 3.31.0× | 8% | 1,420 in 2030+6%/yr |
| Incontinence, prolapse & sacral neuromodulation | 11 | 668+0.3%/yr | +0.3%/yr | 2.01.1× | 0% | 740 in 2030+1.6%/yr |
| Prostatectomy & nephrectomy | 4 | 324+1.3%/yr | +1.3%/yr | 1.10.9× | 0% | 480 in 2030+6.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 10 | 1,256−2.8%/yr | −2.8%/yr | 3.81.2× | 97% | 1,730 in 2030+5.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 40 | 2,686−4.5%/yr | −4.5%/yr | 8.71.0× | 23% | 2,760 in 2030+0.5%/yr |
| Tumor & fibroid embolization | 3 | 119−5.9%/yr | −5.9%/yr | 0.40.6× | 0% | 170 in 2030+6.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 137 | 10,569+19%/yr | +19%/yr | 31.31.1× | 79% | 18,600 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 40 | 1,648−4.1%/yr | −4.1%/yr | 5.21.1× | 0% | 1,830 in 2030+1.8%/yr |
| LAA occlusion & loop recorders | 35 | 1,043+11%/yr | +11%/yr | 2.70.8× | 5% | 1,680 in 2030+8.2%/yr |
| EP ablation | 25 | 921+6%/yr | +6%/yr | 2.30.7× | 0% | 1,750 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 40 | 1,475−9.6%/yr | −9.6%/yr | 3.60.7× | 0% | 1,300 in 2030−2.1%/yr |
| Structural heart (TAVR, TEER) | 32 | 563−1.1%/yr | −1.1%/yr | 1.40.8× | 0% | 1,000 in 2030+10%/yr |
| Mechanical circulatory support | 1 | 152−4.1%/yr | −4.1%/yr | 0.50.8× | 0% | 40 in 2030−18%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 6 | 214+31%/yr | +31%/yr | 0.61.2× | 0% | 330 in 2030+7.6%/yr |
| Stroke thrombectomy | 7 | 176+8.9%/yr | +8.9%/yr | 0.61.3× | 0% | 270 in 2030+7.2%/yr |
| CSF shunts | 1 | 129+5.9%/yr | +5.9%/yr | 0.42.0× | 0% | 250 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 117 | 25,053−0.3%/yr | −0.3%/yr | 74.21.6× | 80% | 30,200 in 2030+3.2%/yr |
| Vitreoretinal surgery | 6 | 441−6.9%/yr | −6.9%/yr | 1.30.7× | 97% | 470 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 245 | 39,442−4.5%/yr | −4.5%/yr | 124.11.0× | 50% | 44,000 in 2030+1.8%/yr |
| ERCP & endoscopic ultrasound | 21 | 1,255−2.8%/yr | −2.8%/yr | 3.91.1× | 0% | 1,450 in 2030+2.4%/yr |
| Bronchoscopy & lung nodule | 12 | 1,083+3.5%/yr | +3.5%/yr | 3.31.1× | 0% | 2,100 in 2030+12%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.